This One Picture Captures Everything Wrong With Wall Street | $VRX

11/05/15 01:19PM EST

Click image to enlarge.

This One Picture Captures Everything Wrong With Wall Street | $VRX - VRX consensus

Source: Bloomberg

Valeant Pharmaceuticals (VRX) is trading around $80, down almost 70% from its August high. Here's the current breakdown of the 25 Wall Street analysts covering the stock:

  • 65% currently rate VRX a Buy
  • The average analyst price target is $199
  • That implies approximately 150% upside

No words.

Reality check. Our Healthcare analysts just released a research note to institutional subscribers outlining why we think shares are worth $20. To be clear, we’ve long been skeptical.

CLICK HERE to read their original Short thesis on VRX from 7/22/14.

© 2024 Hedgeye Risk Management, LLC. The information contained herein is the property of Hedgeye, which reserves all rights thereto. Redistribution of any part of this information is prohibited without the express written consent of Hedgeye. Hedgeye is not responsible for any errors in or omissions to this information, or for any consequences that may result from the use of this information.